AU2003241149A1 - Amorphous clopidogrel hydrogen sulfate composition - Google Patents

Amorphous clopidogrel hydrogen sulfate composition

Info

Publication number: AU2003241149A1
Authority: AU; Australia
Prior art keywords: hydrogen sulfate; clopidogrel hydrogen; sulfate composition; amorphous clopidogrel; amorphous
Prior art date: 2003-05-05
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003241149A

Inventor

Male Srinivas Reddy

Pothireddy Venkateswar Reddy

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Hetero Drugs Ltd

Original Assignee

Hetero Drugs Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-05-05

Filing date

2003-05-05

Publication date

2004-11-26

2003-05-05 Application filed by Hetero Drugs Ltd filed Critical Hetero Drugs Ltd

2004-11-26 Publication of AU2003241149A1 publication Critical patent/AU2003241149A1/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU2003241149A 2003-05-05 2003-05-05 Amorphous clopidogrel hydrogen sulfate composition Abandoned AU2003241149A1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/IN2003/000175 WO2004098593A1 (en)	2003-05-05	2003-05-05	Amorphous clopidogrel hydrogen sulfate composition

Publications (1)

Publication Number	Publication Date
AU2003241149A1 true AU2003241149A1 (en)	2004-11-26

Family

ID=33428275

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003241149A Abandoned AU2003241149A1 (en)	2003-05-05	2003-05-05	Amorphous clopidogrel hydrogen sulfate composition

Country Status (2)

Country	Link
AU (1)	AU2003241149A1 (en)
WO (1)	WO2004098593A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2006074066A1 (en) *	2004-12-30	2006-07-13	Nektar Therapeutics	Non-crystalline formulation comprising clopidogrel
WO2007113857A2 (en) *	2006-04-05	2007-10-11	Cadila Healthcare Limited	Modified release clopidogrel formulation
EP1847258B2 (en)	2006-04-13	2013-01-16	Acino Pharma AG	Partial glycerides as lubricants in pharmaceutical compositions comprising thieno[3,2-c]pyridine derivatives
EP1970054A3 (en)	2007-03-14	2009-06-03	Ranbaxy Laboratories Limited	Clopidogrel tablets
RU2009140792A (en) *	2007-04-09	2011-05-20	Юсв Лимитед (In)	NEW STABLE PHARMACEUTICAL COMPOSITIONS BISULPHATE CLOPIDOGEL AND METHOD FOR PRODUCING THEM
ES2408380T3 (en) *	2007-04-20	2013-06-20	Wockhardt Limited	Clopidogrel pharmaceutical compositions
EP2107061A1 (en)	2008-04-02	2009-10-07	Krka Tovarna Zdravil, D.D., Novo Mesto	Process for the preparation of optically enriched clopidogrel
CN101766573B (en)	2010-02-05	2013-02-13	上海安必生制药技术有限公司	Preparation process of clopidogrel bisulfate solid preparation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2664276B1 (en) *	1990-07-04	1992-10-23	Sanofi Sa	GLYCIDIC THIENYL-2 DERIVATIVE, ITS PREPARATION METHOD AND ITS USE AS A SYNTHESIS INTERMEDIATE.
US5576328A (en) *	1994-01-31	1996-11-19	Elf Sanofi	Method for the secondary prevention of ischemic events
FR2769313B1 (en) *	1997-10-06	2000-04-21	Sanofi Sa	DERIVATIVES OF HYDROXYACETIC ESTERS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS SYNTHESIS INTERMEDIATES

2003
- 2003-05-05 AU AU2003241149A patent/AU2003241149A1/en not_active Abandoned
- 2003-05-05 WO PCT/IN2003/000175 patent/WO2004098593A1/en not_active Ceased

Also Published As

Publication number	Publication date
WO2004098593A1 (en)	2004-11-18

Publication	Publication Date	Title
AU2003234555A1 (en)	2003-12-02	Microcrystalline cewllulose compositions
AU2003287682A8 (en)	2004-06-15	Amorphous alloy stents
GB0329449D0 (en)	2004-01-28	Stem cells
EP1457822A3 (en)	2004-09-22	Positive resist composition
AU2003264337A1 (en)	2005-02-04	Monocycle
SI1612200T1 (en)	2013-10-30	Fertilising composition
AU2003282500A1 (en)	2004-05-04	Anti-corrosion composition
AU2003241149A1 (en)	2004-11-26	Amorphous clopidogrel hydrogen sulfate composition
IL178511A0 (en)	2007-02-11	Stable amorphous cefdinir
AU2003216707A1 (en)	2004-09-30	Amorphous clopidogrel hydrogen sulfate
GB0302929D0 (en)	2003-03-12	Nutrient composition
AU2003263585A1 (en)	2005-03-10	Amorphous duloxetine hydrochloride
GB0314149D0 (en)	2003-07-23	Novel amorphous forms
AU2003902430A0 (en)	2003-06-05	Masterbatch composition
AU2003252320A1 (en)	2005-01-13	Acid-resistant mortar composition
AU2003100144A4 (en)	2003-07-10	Lousicide composition
GB0407620D0 (en)	2004-05-05	Cell lines
AUPS088302A0 (en)	2002-03-28	Metering tap
GB2417421B (en)	2007-05-23	Tooth-whitening composition
AU2003269233A1 (en)	2004-05-04	Soap composition
GB0327906D0 (en)	2004-01-07	Biocatalyst composition
AU2003295616A1 (en)	2005-07-14	Spatial for altering cell proliferation
AU2005100106A4 (en)	2005-05-05	T&L ezyfume
GB0301869D0 (en)	2003-02-26	Composition
HK1100057A (en)	2007-09-07	Amitraz compositions

Legal Events

Date	Code	Title	Description
2006-01-19	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase